Zusammenfassung
Gicht ist eine Stoffwechselkrankheit, die mit erhöhten Harnsäurespiegeln im Serum einhergeht. Diese sind zunächst symptomlos. Gichtkomplikationen entstehen durch kristalline Ausfällung der Harnsäure. In der Synovia von Gelenken führt dies zu schmerzhaften Gichtanfällen, im Gewebe zu immunologischer Reaktion mit Knötchenbildung (Tophi), in der Niere zu Uratsteinen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
European Medicines Agency (2008): CHMP Assessment Report for Adenuric. Internet: http://www.ema.europa.eu/humandocs/PDFs/EPAR/adenuric/H-777-en6.pdf
Janssens H, Lucassen P, Van de Laar F, Janssen M, Van de Lisdonk E (2008): Systemic corticosteroids for acute gout. Cochrane Database Syst Rev. 2008 Apr 16; (2): CD005521.
Lin KC, Lin HY, Chou P (2000): Community based epidemiological study on hyperuricemia and gout in Kin-Hou. J Rheumatol 27: 1045–1050.
Löffler W, Simmonds HA, Gröbner W (1983): Gout and uric acid nephropathy: Some new aspects in diagnosis and treatment. Klin Wochenschr 61: 1223–1239.
Sundy JS (2010): Progress in the pharmacotherapy of gout. Curr Opin Rheumatol 22: 188–193.
Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics (2006a): EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1301–1311.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics (2006b): EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1312–1324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mühlbauer, B., Schmidt, G. (2010). Gichtmittel. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2010. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13380-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-13380-0_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13379-4
Online ISBN: 978-3-642-13380-0
eBook Packages: Medicine (German Language)